Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Seres Therapeutics (MCRB) Interest & Investment Income: 2015-2024

Historic Interest & Investment Income for Seres Therapeutics (MCRB) over the last 10 years, with Dec 2024 value amounting to $4.0 million.

  • Seres Therapeutics' Interest & Investment Income fell 5.21% to $618,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year decrease of 59.66%. This contributed to the annual value of $4.0 million for FY2024, which is 45.66% down from last year.
  • Latest data reveals that Seres Therapeutics reported Interest & Investment Income of $4.0 million as of FY2024, which was down 45.66% from $7.3 million recorded in FY2023.
  • In the past 5 years, Seres Therapeutics' Interest & Investment Income registered a high of $7.3 million during FY2023, and its lowest value of $946,000 during FY2020.
  • For the 3-year period, Seres Therapeutics' Interest & Investment Income averaged around $4.8 million, with its median value being $4.0 million (2024).
  • In the last 5 years, Seres Therapeutics' Interest & Investment Income soared by 203.38% in 2021 and then crashed by 45.66% in 2024.
  • Seres Therapeutics' Interest & Investment Income (Yearly) stood at $946,000 in 2020, then skyrocketed by 203.38% to $2.9 million in 2021, then climbed by 6.55% to $3.1 million in 2022, then soared by 138.75% to $7.3 million in 2023, then slumped by 45.66% to $4.0 million in 2024.